logo

Mannkind Corp. (MNKD)



Trade MNKD now with
  Date
  Headline
10/4/2021 7:06:44 AM MannKind Enrolls First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population
9/7/2021 6:02:47 AM United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At European Respiratory Society International Congress 2021
8/4/2021 6:54:10 AM MannKind Partners With NRx Pharm To Explore Dry Powder Formulation Of ZYESAMI Based On Technosphere Platform
6/16/2021 11:02:35 AM MannKind : FDA Accepts For Priority Review Of NDA For Tyvaso DPI For Treatment Of PAH And PH-ILD
6/3/2021 6:03:41 AM MannKind Presents A Post Hoc Analysis From STAT Study
4/19/2021 6:08:32 AM MannKind, United Therapeutics Reach Milestone In Development Of Tyvaso DPI
3/2/2021 6:36:16 AM MannKind Prices Upsized $200.0 Mln Convertible Senior Notes Offering
3/1/2021 7:14:35 AM MannKind Intends To Offer $150.0 Mln Of Convertible Senior Notes Due 2026
2/25/2021 8:09:42 AM MannKind Q4 Loss/Shr $0.11 Vs Loss $0.07 Last Year
2/24/2021 8:01:34 AM Vertice Launches THYQUIDITY Oral Solution